Strategic acquisition Labrix is now part of Doctor’s Data Inc., enabling sales conversations around expanded test menus, clinical education, and global provider reach to cross-sell via a broader family of functional and toxicology tests.

Clinical heritage Founders bring extensive laboratory medicine and clinical practice experience, which can be leveraged to position Labrix as a trusted partner for comprehensive hormone, neurotransmitter, and neuroendocrine testing solutions.

Test menu depth With a history of saliva testing accuracy and a broadened test portfolio post-acquisition, target practitioners seeking non-invasive, multi-dimensional functional testing to enhance patient assessment and outcomes.

Mid-market focus Company size (11-50 employees) and revenue range suggest mid-market clinics and specialty centers as primary targets for partnerships, enabling scalable B2B collaborations and volume-based opportunities.

Tech-enabled ops Existing tech stack and digital presence offer opportunities to streamline ordering, data integration, and reporting for partner labs and clinics, supporting improved clinician onboarding and utilization.